Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:01 pm Sale |
2024-12-31 | 13G | Vinci Partners Investments Ltd. VINP |
Samlyn Capital, LLC | 2,360,265 6.200% |
-269,306 (-10.24%) |
Filing History |
| 2025-02-14 1:59 pm Sale |
2024-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Samlyn Capital, LLC | 0 0.000% |
-3,372,558 (Position Closed) |
Filing History |
| 2025-02-14 1:57 pm Sale |
2024-12-31 | 13G | PureCycle Technologies, Inc. PCT |
Samlyn Capital, LLC | 11,668,311 6.500% |
-3,184,402 (-21.44%) |
Filing History |
| 2025-02-14 1:53 pm Purchase |
2024-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 6,667,105 9.800% |
403,347 (+6.44%) |
Filing History |
| 2025-02-14 1:49 pm Purchase |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Samlyn Capital, LLC | 9,667,048 5.200% |
9,667,048 (New Position) |
Filing History |
| 2024-11-14 1:34 pm Sale |
2024-09-30 | 13G | Merus N.V. MRUS |
Samlyn Capital, LLC | 2,610,393 3.800% |
-802,017 (-23.50%) |
Filing History |
| 2024-11-01 4:37 pm Purchase |
2024-11-01 | 13D | Applied Minerals, Inc. AMNL |
Samlyn Capital, LLC | 96,681,256 19.800% |
11,536,928 (+13.55%) |
Filing History |
| 2024-09-20 5:18 pm Purchase |
2024-09-11 | 13G | PureCycle Technologies, Inc. PCT |
Samlyn Capital, LLC | 14,852,713 8.200% |
5,828,505 (+64.59%) |
Filing History |
| 2024-08-01 9:18 pm Sale |
2024-08-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 6,263,758 9.990% |
-4,226 (-0.07%) |
Filing History |
| 2024-05-13 4:52 pm Purchase |
2024-05-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 6,267,984 9.990% |
3,771,725 (+151.10%) |
Filing History |
| 2024-03-11 4:38 pm Unchanged |
2024-03-07 | 13D | Applied Minerals, Inc. AMNL |
Samlyn Capital, LLC | 85,144,328 17.600% |
0 (Unchanged) |
Filing History |
| 2024-02-14 1:49 pm Purchase |
2023-12-31 | 13G | Vinci Partners Investments Ltd. VINP |
Samlyn Capital, LLC | 2,629,571 6.500% |
247,684 (+10.40%) |
Filing History |
| 2024-02-14 1:46 pm Sale |
2023-12-31 | 13G | PureCycle Technologies, Inc. PCT |
Samlyn Capital, LLC | 9,024,208 5.400% |
-2,520,462 (-21.83%) |
Filing History |
| 2024-02-14 1:44 pm Purchase |
2023-12-31 | 13G | Merus N.V. MRUS |
Samlyn Capital, LLC | 3,412,410 5.900% |
3,412,410 (New Position) |
Filing History |
| 2024-02-14 1:40 pm Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Samlyn Capital, LLC | 3,372,558 5.500% |
3,372,558 (New Position) |
Filing History |
| 2024-02-14 1:31 pm Purchase |
2023-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 2,496,259 5.100% |
2,496,259 (New Position) |
Filing History |
| 2024-01-05 5:00 pm Purchase |
2024-01-01 | 13D | Applied Minerals, Inc. AMNL |
Samlyn Capital, LLC | 85,144,328 17.800% |
6,017,588 (+7.60%) |
Filing History |
| 2023-02-14 2:22 pm Sale |
2022-12-31 | 13G | Climb Bio, Inc. CLYM |
Samlyn Capital, LLC | 0 0.000% |
-2,128,202 (Position Closed) |
Filing History |
| 2023-02-14 1:47 pm Sale |
2022-12-31 | 13G | Glass Houses Acquisition Corp. GLHA |
Samlyn Capital, LLC | 0 0.000% |
-1,260,198 (Position Closed) |
Filing History |
| 2023-02-14 1:46 pm Sale |
2022-12-31 | 13G | Perella Weinberg Partners PWP |
Samlyn Capital, LLC | 0 0.000% |
-2,993,365 (Position Closed) |
Filing History |